Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial of mitomycin C and ifosfamide for metastatic pancreatic cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
This update details a completed Phase 1/2 trial evaluating the safety and preliminary efficacy of P276-00 in combination with gemcitabine fo…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer [Phase 2, Phase 3]
Update on a Phase 2/3 clinical trial comparing gemcitabine alone to a combination chemotherapy regimen followed by chemoradiation for stage …
-
CLINICAL_TRIALS trial_result · 2011-12-21Clinical Trial Update: Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of gemcitabine, erlotinib, and sorafenib (GES) in metastatic pancreatic cancer has compl…
-
CLINICAL_TRIALS trial_result · 2011-12-14Clinical Trial Update: Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
A completed Phase 2 clinical trial evaluating paclitaxel for unresectable locally advanced or metastatic pancreatic cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer [Phase 2]
This update covers a Phase 2 neoadjuvant trial using FDR GX in locally advanced pancreatic cancer, which has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-06Clinical Trial Update: Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer [Phase 2]
This document reports a randomized Phase II trial comparing FOLFOX versus FOLFIRI.3 in gemcitabine-refractory pancreatic cancer, and notes t…
-
CLINICAL_TRIALS trial_result · 2011-12-01Clinical Trial Update: First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating first-line gemcitabine with or without sunitinib in advanced or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma [Phase 1]
Phase I/II trial evaluating radiation with bevacizumab (Avastin) and erlotinib (Tarceva) for pancreatic cancer has completed. Results were p…
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated capecitabine and oxaliplatin with radiotherapy in patients with unresectable gastrointestinal cancers, …
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial of Erlotinib in combination with Everolimus (RAD001) for previously treated advanced pancreatic cancer was terminated; resul…
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Anastomotic Techniques in Pancreaticoduodenectomy [NA]
Update on a clinical trial evaluating anastomotic techniques in pancreaticoduodenectomy. The status of the trial is unknown.
-
CLINICAL_TRIALS trial_result · 2011-09-21Clinical Trial Update: Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating gemcitabine with or without oxaliplatin in locally advanced or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study of preoperative intratumor dendritic cell immunotherapy for pancreatic cancer. The spons…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: An Algorithm for Intra-operative Goal-directed Haemodynamic Management in Non-cardiac Surgery
Clinical trial update describing an intra-operative goal-directed haemodynamic management algorithm for non-cardiac surgery, with studied co…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Impact of Microparticles on Postoperative Complications in Surgical Patients
This clinical trial update reports on the impact of microparticles on postoperative complications in surgical patients, including those with…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy [Phase 2]
Phase 2 trial of panobinostat with bortezomib in pancreatic cancer progressing on gemcitabine has been terminated; results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating imatinib mesylate in combination with gemcitabine for locally advanced, metastatic, or recurrent pancreatic cancer;…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction [Phase 4]
Phase 4 clinical trial update on metal biliary stents for distal malignant biliary obstruction. The study involves cancers of the pancreas, …
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating oral MKC-1 in unresectable or metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Cancer in Patients With Gabapentin (GPRD)
This clinical trial update reports cancer outcomes in patients treated with gabapentin, with results posted in 2011. It lists several cancer…
-
FDA approval · 2011-07-25FDA Approved: GEMCITABINE HYDROCHLORIDE — Original Application (Teyro Labs Private Limited)
The FDA approved an original ANDA for gemcitabine hydrochloride from Teyro Labs Private Limited, enabling its generic use.
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer [Phase 2]
This Phase 2 trial evaluated fixed-dose-rate gemcitabine and cisplatin followed by chemoradiation for locally advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer [Phase 2]
This Phase 2 trial evaluates adjuvant gemcitabine and cisplatin followed by chemoradiation for resected pancreatic cancer; the study status …
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating irinotecan and docetaxel with or without cetuximab in metastatic pancreatic cancer has completed with posted result…